Literature DB >> 19841387

Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment.

Y Dauvilliers1, B Abril, E Mas, F Michel, M Tafti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19841387     DOI： 10.1212/WNL.0b013e3181bd1344

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  25 in total

1.  The trouble with Tribbles: do antibodies against TRIB2 cause narcolepsy?

Authors:  Andrew S P Lim; Thomas E Scammell
Journal:  Sleep       Date:  2010-07       Impact factor: 5.849

2.  Furthering the understanding of the pathophysiology of narcolepsy.

Authors:  Michael J Thorpy
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

Review 3.  Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.

Authors:  Steven T Szabo; Michael J Thorpy; Geert Mayer; John H Peever; Thomas S Kilduff
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

Review 4.  Narcolepsy Associated with Pandemrix Vaccine.

Authors:  Tomi Sarkanen; Anniina Alakuijala; Ilkka Julkunen; Markku Partinen
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-01       Impact factor: 5.081

5.  [Narcolepsy].

Authors:  G Mayer
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

6.  Diagnosis and management of central hypersomnias.

Authors:  Karel Sonka; Marek Susta
Journal:  Ther Adv Neurol Disord       Date:  2012-09       Impact factor: 6.570

Review 7.  Current treatment of selected pediatric sleep disorders.

Authors:  Shannon S Sullivan
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

8.  Narcolepsy in the pediatric population.

Authors:  Erick N Viorritto; Suraiya A Kureshi; Judith A Owens
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

Review 9.  Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment.

Authors:  Lucie Barateau; Roland Liblau; Christelle Peyron; Yves Dauvilliers
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

10.  Increased immune complexes of hypocretin autoantibodies in narcolepsy.

Authors:  Aude Deloumeau; Sophie Bayard; Quentin Coquerel; Pierre Déchelotte; Christine Bole-Feysot; Bertrand Carlander; Valérie Cochen De Cock; Sergueï O Fetissov; Yves Dauvilliers
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.